atropine: be given with neostigmine

Property	Similarity
be given with neostigmine	1.00
be administered with neostigmine	0.91
be given before irinotecan	0.79
be given for bradycardia	0.79
be given with irinotecan	0.79
is administered preoperatively	0.78
be given with diphenoxylate	0.76
be contraindicated in prostatic hypertrophy	0.76
is given	0.75
be given before intubation	0.75

0.65

Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.91

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.51

¬ Salient(atropine, be administered with neostigmine)

0.64

Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.91

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.42

¬ Typical(atropine, be administered with neostigmine)

0.64

Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.91

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.44

¬ Plausible(atropine, be administered with neostigmine)

0.62

Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.79

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.24

¬ Remarkable(atropine, be given for bradycardia)

0.62

Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.91

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.67

¬ Remarkable(atropine, be administered with neostigmine)

0.61

Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.79

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.31

¬ Salient(atropine, be given for bradycardia)

0.58

Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.75

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.22

¬ Typical(atropine, is given)

0.58

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.42

¬ Salient(atropine, is administered preoperatively)

0.57

Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.78

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.45

¬ Remarkable(atropine, is administered preoperatively)

0.57

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.76

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.37

¬ Remarkable(atropine, be given with diphenoxylate)

0.57

Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.75

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.38

¬ Remarkable(atropine, be given before intubation)

0.57

Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.52

¬ Remarkable(atropine, be given before irinotecan)

0.55

Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.79

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.43

¬ Plausible(atropine, be given for bradycardia)

0.55

Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.76

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.48

¬ Salient(atropine, be given with diphenoxylate)

0.54

Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.45

¬ Plausible(atropine, is administered preoperatively)

0.54

Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.75

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.39

¬ Plausible(atropine, is given)

0.53

Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.68

¬ Remarkable(atropine, be given with irinotecan)

0.53

Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.79

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.50

¬ Typical(atropine, be given with irinotecan)

0.53

Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.75

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.57

¬ Salient(atropine, is given)

0.52

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.79

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.70

¬ Salient(atropine, be given with irinotecan)

0.52

Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.52

¬ Typical(atropine, is administered preoperatively)

0.50

Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.76

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.54

¬ Plausible(atropine, be given with diphenoxylate)

0.49

Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.79

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.87

¬ Salient(atropine, be given before irinotecan)

0.49

Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.78

¬ Remarkable(atropine, be contraindicated in prostatic hypertrophy)

0.49

Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.79

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.65

¬ Typical(atropine, be given for bradycardia)

0.48

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.79

¬ Salient(atropine, be contraindicated in prostatic hypertrophy)

0.48

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.59

¬ Typical(atropine, be contraindicated in prostatic hypertrophy)

0.48

Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.75

Evidence: 0.68

Salient(atropine, be given with neostigmine) ⋁

Evidence: 0.80

¬ Salient(atropine, be given before intubation)

0.48

Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.76

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.63

¬ Plausible(atropine, be contraindicated in prostatic hypertrophy)

0.47

Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.75

Evidence: 0.69

Remarkable(atropine, be given with neostigmine) ⋁

Evidence: 0.86

¬ Remarkable(atropine, is given)

0.46

Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.76

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.68

¬ Typical(atropine, be given with diphenoxylate)

0.44

Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.79

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.84

¬ Plausible(atropine, be given before irinotecan)

0.42

Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.79

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.90

¬ Typical(atropine, be given before irinotecan)

0.41

Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.79

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.92

¬ Plausible(atropine, be given with irinotecan)

0.40

Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.75

Evidence: 0.58

Typical(atropine, be given with neostigmine) ⋁

Evidence: 0.88

¬ Typical(atropine, be given before intubation)

0.38

Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.75

Evidence: 0.58

Plausible(atropine, be given with neostigmine) ⋁

Evidence: 0.98

¬ Plausible(atropine, be given before intubation)

Parents	drug Weight: 0.66 , alkaloid Weight: 0.59 , agent Weight: 0.57 , substance Weight: 0.55 , medicine Weight: 0.51
Siblings	phenobarbital Weight: 0.36 , acetaminophen Weight: 0.36 , ibuprofen Weight: 0.35 , morphine Weight: 0.35 , metronidazole Weight: 0.35

atropine: be given with neostigmine

Related concepts

Related properties

Priors about this statement

Cues

Evidence

Clauses

Remarkability exclusitivity between siblings

Remarkability from sibling implausibility

Salient implies Plausible

Similarity expansion

Typical and Remarkable implies Salient

Typical implies Plausible

Typicality and Rermarkability incompatibility between siblings